Command Palette

Search for a command to run...

MEDANTA

1357.8+0.62%
Market Cap
₹36,253.10 Cr
Stock P/E
67.87
ROCE
20.50%
ROE
15.31%
Book Value
₹132.23

Financials

YoY Net Sales
EPS Growth
Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Institution
Public
Others

From Last Concall

POSITIVES
  • Record quarterly top-line and EBITDA, with stable margins.
  • 550-bed Noida facility expected to commence operation soon.
NEGATIVES
  • Margin pressure in mature hospitals due to salary increments in Q1.
  • Lucknow developing hospitals saw ARPOB decline due to longer ALOS.

Peers Summary

Deep Value Pick

Global Health Ltd. shows promising growth and profitability metrics compared to its peers, positioning it as a compelling investment option. While its valuation appears high, its strong ROE and manageable debt levels indicate potential for sustainable growth. Conversely, companies like Fortis Healthcare exhibit concerning debt levels and profitability metrics, making them financially risky.

Key Points
  • Global Health Ltd. has a strong ROE of 15.31% and a manageable debt-equity ratio of 0.0968.
  • Apollo Hospitals is a strong performer with the highest ROE and attractive EBITDA margins.
  • Fortis Healthcare is financially weak with a very high PE ratio and low profitability.
  • Aster DM Healthcare stands out as a deep value pick with a low PE but shows negative revenue growth.
  • Max Healthcare appears overvalued with a high PE and low ROE.
Top Performers
Apollo Hospitals Enterprise Ltd.

Highest ROE at 20.51% and strong EPS growth.

Narayana Hrudayalaya Ltd.

Strong profitability metrics with high ROE and decent growth.

Global Health Ltd.

Solid growth trajectory and profitability, strong cash flow metrics.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.